Can your genes guide better mental health meds? new trial aims to find out
NCT ID NCT05656469
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether using a person's genetic information to guide medication choices leads to better recovery for people with mood, anxiety, or psychotic disorders. Over 2,500 participants will receive either standard care or personalized medication advice based on their genetic profile. The goal is to see if this approach improves mental health recovery over 24 weeks.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- pharmacogenetic testing
- What this could lead to
- If successful, this could make psychiatric medication more personalized, potentially improving recovery rates and reducing trial-and-error prescribing.
- What could go wrong
- This is a large but early-stage trial; genetic testing may not consistently improve outcomes, and results may not apply to all patients or settings.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANXIETY DISORDERS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Babeş-Bolyai University, Department of Clinical Psychology and Psychotherapy
RECRUITINGCluj-Napoca, Romania
-
Fundació Clínic per a la Recerca Biomèdica, Department of Psychiatry and Psychology, Hospital Clínic
RECRUITINGBarcelona, Spain
-
King's College, Institute of Psychiatry, Psychology & Neuroscience
RECRUITINGLondon, United Kingdom
-
Ludwig-Maximilian University, University Hospital, Institute of Psychiatric Phenomics and Genomics (IPPG)
RECRUITINGMünchen, Germany
-
Maastricht University, Department of Psychiatry and Neuropsychology
RECRUITINGMaastricht, Netherlands
-
Parnassia Psychiatric Institute, Department of Psychiatry
RECRUITINGAmsterdam, Netherlands
-
SUNY Upstate Medical University, Department of Psychiatry and Behavioural Sciences
NOT_YET_RECRUITINGSyracuse, New York, 13210, United States
-
University Hospital Bonn, Department of Psychiatry and Psychotherapy
RECRUITINGBonn, Germany
-
University of Belgrade, Faculty of Pharmacy
RECRUITINGBelgrade, Serbia
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a new pill for schizophrenia pass its first human test?
- Can a structured care pathway ease teen depression?
- Middle school jitters: a new program aims to smooth the transition for anxious students
- Can a nasal spray break through tough depression?
- Could a new drug offer hope for Treatment-Resistant depression?
- Can virtual reality help quiet paranoia in schizophrenia?